Details for Patent: 5,968,914
✉ Email this page to a colleague
Summary for Patent: 5,968,914
| Title: | Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
| Abstract: | The subject invention discloses compounds, compositions and methods for treatment and prevention of toxicity due to chemotherapeutic agents and antiviral agents. Disclosed are acylated derivatives of non-methylated pyrimidine nucleosides. These compounds are capable of attenuating damage to the hematopoietic system in animals receiving antiviral or antineoplastic chemotherapy. |
| Inventor(s): | von Borstel; Reid (Potomac, MD), Bamat; Michael K. (Potomac, MD) |
| Assignee: | Pro-Neuron, Inc. (Rockville, MD) |
| Application Number: | 08/472,210 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 5,968,914
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,968,914
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 142221 | ⤷ Sign Up | |||
| Austria | 179615 | ⤷ Sign Up | |||
| Austria | 205850 | ⤷ Sign Up | |||
| Austria | 243039 | ⤷ Sign Up | |||
| Austria | 282627 | ⤷ Sign Up | |||
| Austria | 320813 | ⤷ Sign Up | |||
| Austria | 93236 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
